-
Syringe service providers will be required to report syringe return rates to the state health department, and provide free disposal services to the public.
-
The Lebanon-based hospital comes in third in terms of number of babies delivered at New Hampshire hospitals, but delivers the most babies with substance exposure.
-
Over the weekend, 347 students graduated as registered nurses from community colleges across the state. It’s the biggest class to graduate in over a decade.
-
Gov. Kelly Ayotte has largely stayed out of the legislative fray in her first term. But in recent days, she’s issued a volley of press releases and worked the phones for a bill on insurance coverage for a children’s mental health program.
-
Many of the concerns of abuse or improper restraint have been detailed in reports by the Disability Rights Center and the New Hampshire Office of the Child Advocate.
-
Andrea Brault is fighting acute myeloid leukemia and needs a bone marrow transplant. But finding a donor match can be more challenging for people of color.
-
State health officials say the two individuals are not in New Hampshire, but declined to say where they are currently being monitored.
-
When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer care.
-
Donnalee Lozeau is the director of a new statewide program that will distribute roughly $200 million in federal funding this year toward rural healthcare needs in New Hampshire. Over five years, the state expects to receive a total of $1 billion dollars.
-
New Hampshire's Therapeutic Cannabis Program saw a 15% increase in patients last year.
-
Attorney General John Formella announces that New Hampshire would get about $30 million from the $7.4 billion opioid settlement reached with Purdue Pharma and its owners, the Sackler family. The money will go toward drug treatment and recovery.
-
Abortion advocates had alternative options but say mifepristone remains safe and effective.